• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

林奇综合征男性患者的前列腺癌发病率。

Prostate cancer incidence in males with Lynch syndrome.

作者信息

Haraldsdottir Sigurdis, Hampel Heather, Wei Lai, Wu Christina, Frankel Wendy, Bekaii-Saab Tanios, de la Chapelle Albert, Goldberg Richard M

机构信息

Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, USA.

Division of Human Genetics, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio, USA.

出版信息

Genet Med. 2014 Jul;16(7):553-7. doi: 10.1038/gim.2013.193. Epub 2014 Jan 16.

DOI:10.1038/gim.2013.193
PMID:24434690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4289599/
Abstract

PURPOSE

An increased risk of prostate cancer is currently not considered a part of the Lynch syndrome spectrum. The purpose of this study was to retrospectively examine prostate cancer incidence in the Lynch syndrome cohort at the Ohio State University in comparison with that in the general population.

METHODS

We included all males diagnosed with Lynch syndrome from June 1998 to June 2012 at the Ohio State University and obtained baseline information including cancer history. If patients had not been seen in the 12 months before June 2012, they were contacted to document changes in their cancer history. We compared prostate cancer incidence among the Lynch syndrome families with that of the general population by using the Surveillance, Epidemiology, and End RESULTS registry 1999-2009.

RESULTS

Of the 188 males identified with Lynch syndrome, 11 males were diagnosed with prostate cancer during the study period. The ratio of observed to expected numbers of prostate cancer cases resulted in a standardized rate ratio of 4.87 (95% confidence interval: 2.43-8.71). Impaired mismatch repair expression and microsatellite instability were seen in one out of two prostate cancer specimens available for testing.

CONCLUSION

Males with Lynch syndrome had a nearly fivefold increased risk of developing prostate cancer but did not appear to have earlier onset or a more aggressive phenotype.

摘要

目的

目前前列腺癌风险增加不被视为林奇综合征谱系的一部分。本研究的目的是回顾性研究俄亥俄州立大学林奇综合征队列中前列腺癌的发病率,并与普通人群进行比较。

方法

我们纳入了1998年6月至2012年6月在俄亥俄州立大学被诊断为林奇综合征的所有男性,并获取了包括癌症病史在内的基线信息。如果患者在2012年6月前的12个月内未就诊,则与他们联系以记录其癌症病史的变化。我们使用1999 - 2009年监测、流行病学和最终结果登记处的数据,比较了林奇综合征家族中前列腺癌的发病率与普通人群的发病率。

结果

在188名确诊为林奇综合征的男性中,有11名男性在研究期间被诊断出患有前列腺癌。观察到的前列腺癌病例数与预期病例数之比得出标准化发病率比为4.87(95%置信区间:2.43 - 8.71)。在可供检测的两份前列腺癌标本中,有一份出现错配修复表达受损和微卫星不稳定。

结论

患有林奇综合征的男性患前列腺癌的风险增加了近五倍,但似乎没有更早发病或更具侵袭性的表型。

相似文献

1
Prostate cancer incidence in males with Lynch syndrome.林奇综合征男性患者的前列腺癌发病率。
Genet Med. 2014 Jul;16(7):553-7. doi: 10.1038/gim.2013.193. Epub 2014 Jan 16.
2
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.子宫内膜癌患者中林奇综合征(遗传性非息肉病性结直肠癌)的筛查。
Cancer Res. 2006 Aug 1;66(15):7810-7. doi: 10.1158/0008-5472.CAN-06-1114.
3
Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.斯洛文尼亚结直肠癌患者种系 MLH1、MSH2、MSH6 和 PMS2 基因突变的筛查:对林奇综合征人群特异性检测策略的影响。
Fam Cancer. 2009;8(4):421-9. doi: 10.1007/s10689-009-9258-4. Epub 2009 Jun 13.
4
Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.在诊断性活检上应用 DNA 错配修复免疫组化进行林奇综合征的术前诊断。
Dis Colon Rectum. 2011 Dec;54(12):1480-7. doi: 10.1097/DCR.0b013e318231db1f.
5
Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).林奇综合征(MLH1、MSH2、MSH6、PMS2)临床应用基因卡
Eur J Hum Genet. 2010 Sep;18(9). doi: 10.1038/ejhg.2009.232. Epub 2010 Jan 27.
6
[Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].[我们是否应该对上尿路癌患者进行林奇综合征的系统筛查?]
Bull Cancer. 2014 Feb;101(2):144-50. doi: 10.1684/bdc.2014.1896.
7
Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing.林奇综合征相关癌症患者的识别:基于组织的错配修复检测中的临床显著差异和问题。
Cancer Prev Res (Phila). 2012 Feb;5(2):320-7. doi: 10.1158/1940-6207.CAPR-11-0288. Epub 2011 Nov 15.
8
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.联合微卫星不稳定性、MLH1甲基化分析及免疫组织化学用于妇科肿瘤学组GOG210子宫内膜癌林奇综合征筛查:一项NRG肿瘤学与妇科肿瘤学组研究
J Clin Oncol. 2015 Dec 20;33(36):4301-8. doi: 10.1200/JCO.2015.63.9518. Epub 2015 Nov 9.
9
Lynch Syndrome in Thai Endometrial Cancer Patients.林奇综合征与泰国子宫内膜癌患者。
Asian Pac J Cancer Prev. 2021 May 1;22(5):1477-1483. doi: 10.31557/APJCP.2021.22.5.1477.
10
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.林奇综合征女性子宫内膜癌后结直肠癌和其他癌症的风险。
J Natl Cancer Inst. 2013 Feb 20;105(4):274-9. doi: 10.1093/jnci/djs525. Epub 2013 Feb 5.

引用本文的文献

1
Germline BRCA2 Mutation and Lynch Syndrome in a Patient With Multiple Primary Malignancies.一名患有多种原发性恶性肿瘤患者的胚系BRCA2突变与林奇综合征
Case Rep Oncol Med. 2025 Aug 20;2025:5879510. doi: 10.1155/crom/5879510. eCollection 2025.
2
Prostate cancer genetic background. The introduction of genetic testing in the determination of high-risk prostate cancer cases and selection of targeted chemotherapy in advanced prostate cancer patients.前列腺癌的遗传背景。基因检测在高危前列腺癌病例判定及晚期前列腺癌患者靶向化疗选择中的应用。
Cent European J Urol. 2024;77(4):625-636. doi: 10.5173/ceju.2024.0049. Epub 2024 Dec 17.
3
Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men.罕见的致病性结构变异显示出增强非洲男性前列腺癌种系检测的潜力。
Nat Commun. 2025 Mar 10;16(1):2400. doi: 10.1038/s41467-025-57312-9.
4
Integrating BRCA testing into routine prostate cancer care: a multidisciplinary approach by SIUrO and other Italian Scientific Societies.将BRCA检测纳入前列腺癌常规诊疗:SIUrO及其他意大利科学学会的多学科方法
BMC Cancer. 2025 Jan 23;25(1):127. doi: 10.1186/s12885-025-13521-5.
5
The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers.泌尿系统肿瘤的不断变化的分子谱和可操作的改变。
Curr Oncol. 2024 Nov 6;31(11):6909-6937. doi: 10.3390/curroncol31110511.
6
Utility of pembrolizumab for metastatic castrate resistant prostate cancer with MMR deficiency.帕博利珠单抗用于微卫星错配修复缺陷的转移性去势抵抗性前列腺癌的效用。
Urol Case Rep. 2024 Aug 30;57:102833. doi: 10.1016/j.eucr.2024.102833. eCollection 2024 Nov.
7
Rare pathogenic structural variants show potential to enhance prostate cancer germline testing for African men.罕见的致病性结构变异显示出增强非洲男性前列腺癌种系检测的潜力。
Res Sq. 2024 Jun 13:rs.3.rs-4531885. doi: 10.21203/rs.3.rs-4531885/v1.
8
Screening guidelines for individuals at increased risk for prostate cancer.前列腺癌高危个体的筛查指南。
Can Urol Assoc J. 2024 Oct;18(10):E301-E307. doi: 10.5489/cuaj.8710.
9
2023 Canadian Urological Association guideline: Genetic testing in prostate cancer.2023年加拿大泌尿外科协会指南:前列腺癌的基因检测
Can Urol Assoc J. 2023 Oct;17(10):314-325. doi: 10.5489/cuaj.8588.
10
Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer.前列腺癌中DNA损伤和错配修复基因的突变谱。
Front Genet. 2023 Sep 4;14:1231536. doi: 10.3389/fgene.2023.1231536. eCollection 2023.

本文引用的文献

1
Elevated risk of prostate cancer among men with Lynch syndrome.林奇综合征男性前列腺癌风险升高。
J Clin Oncol. 2013 May 10;31(14):1713-8. doi: 10.1200/JCO.2012.44.1238. Epub 2013 Mar 25.
2
Risks of less common cancers in proven mutation carriers with lynch syndrome.林奇综合征明确突变携带者中少见癌症的风险。
J Clin Oncol. 2012 Dec 10;30(35):4409-15. doi: 10.1200/JCO.2012.43.2278. Epub 2012 Oct 22.
3
The spectrum of urological malignancy in Lynch syndrome.林奇综合征中的泌尿系统恶性肿瘤谱。
Fam Cancer. 2013 Mar;12(1):57-63. doi: 10.1007/s10689-012-9573-z.
4
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.林奇综合征患者结直肠癌后发生原发性结外癌症的风险。
J Natl Cancer Inst. 2012 Sep 19;104(18):1363-72. doi: 10.1093/jnci/djs351. Epub 2012 Aug 28.
5
Comprehensive molecular characterization of human colon and rectal cancer.全面的人类结肠和直肠癌分子特征分析。
Nature. 2012 Jul 18;487(7407):330-7. doi: 10.1038/nature11252.
6
Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.DNA 错配修复基因突变携带者的癌症谱:来自基于医院的林奇综合征登记处的结果。
Fam Cancer. 2012 Sep;11(3):441-7. doi: 10.1007/s10689-012-9534-6.
7
Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases.乳腺癌和林奇综合征:突变携带者、非携带者和散发性病例中肿瘤的分子分析。
Breast Cancer Res. 2012 Jun 12;14(3):R90. doi: 10.1186/bcr3205.
8
Hereditary prostate cancer as a feature of Lynch syndrome.遗传性前列腺癌作为林奇综合征的一个特征。
Fam Cancer. 2011 Mar;10(1):37-42. doi: 10.1007/s10689-010-9388-8.
9
American Cancer Society guideline for the early detection of prostate cancer: update 2010.美国癌症协会前列腺癌早期检测指南:2010 年更新版。
CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3.
10
Germ-line mutations in mismatch repair genes associated with prostate cancer.与前列腺癌相关的错配修复基因中的种系突变。
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2460-7. doi: 10.1158/1055-9965.EPI-09-0058. Epub 2009 Sep 1.